AWARDDELIVERY ORDEROther than small business
Delivery order HHSN27200024ADVANCED BIOSCIENCE LABORATORIES, INC.
Overview
Award facts
- Net obligations
- $7.71M
- $7,712,780of $7.93M potential value
- Outlays (paid to date)
- $317.92K
- $317.92K paid of $7.71M obligated$317,924
- Period of performance
- Sep 26, 2014 to Jun 30, 2025
- Ended
- Modifications
- 6
- Latest action Apr 11, 2025
- Contract type
- Delivery order
- PIID HHSN27200024
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS
Dates and value
- Award date
- Signed on Sep 26, 2014
- Potential end of performance
- Jun 29, 2025
- Current value
- $7,712,780Base and exercised options
- Potential value (if all options are exercised)
- $7,930,252
- Parent contract vehicle
- HHSN272201100021I (IDC, single award) — 37 orders recorded under it
Obligations by fiscal year of action
- FY2025: $46,812
- FY2022: $84,531
- FY2021: $84,106
- FY2020: $79,856
- FY2019: $125,391
- FY2014: $7,292,084
Total across 6 fiscal years: $7,712,780
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 11, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationROCKVILLE, MD
UEIMK4QC9EKZXG8
CAGE code4KCY8
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyCOMPAGNIE MERIEUX ALLIANCE
Business types and certifications
Foreign-ownedFor-profit organizationCorporation (not tax-exempt)Manufacturer of goods
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Rockville, Montgomery County, Maryland 20850-3772
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN81R&D- MEDICAL: AIDS RESEARCH (BASIC RESEARCH) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan required - incentive not includedC
- Major program
- Niaid preclinical development support - production of HCMV-TR3∆PP71 hivgag for clinical trials
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- Sep 26, 2014Base obligation at award: $7,292,084
- Latest action
- Apr 11, 2025 — Funding onlyModification P00006; obligation change +$46,812; funding only: changes obligations, not scope
- Latest substantive action
- Jul 20, 2022 — Change orderModification P00005; obligation change +$84,531
- Latest funding action
- Apr 11, 2025 — Funding onlyModification P00006; obligation change +$46,812; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Change order3
- Funding only2
- Supplemental agreement (within scope)1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $46,812
- Latest action: change in base and all options
- $46,812
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- National Institutes Of Health7529
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 7
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2014/2014-0885-000
- 075-2019/2019-0885-000
- 075-2020/2020-0885-000
- 075-2021/2021-0885-000
- 075-2022/2022-0885-000
- 075-2025/2025-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression